Summary

Breast Biopsy Devices Market – Scope of Report
TMR’s report on the global breast biopsy devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global breast biopsy devices market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global breast biopsy devices market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the breast biopsy devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global breast biopsy devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global breast biopsy devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global breast biopsy devices market.

The report delves into the competitive landscape of the global breast biopsy devices market. Key players operating in the global breast biopsy devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global breast biopsy devices market profiled in this report.

Key Questions Answered in Global breast biopsy devices Market Report
• What is the sales/revenue generated by breast biopsy devices across all regions during the forecast period?
• What are the opportunities in the global breast biopsy devices market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Breast Biopsy Devices Market – Research Objectives and Research Approach
The comprehensive report on the global breast biopsy devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global breast biopsy devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global breast biopsy devices market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Breast Biopsy Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Breast Biopsy Devices Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Breast Biopsy Devices Market Analysis and Forecast, by Product Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2020-2034
6.3.1. Core Needle Biopsy Devices
6.3.2. Vacuum-assisted Biopsy Devices
6.3.3. Fine Needle Aspiration Biopsy Devices
6.3.4. Surgical Biopsy Devices
6.3.5. Others
6.4. Market Attractiveness, by Product Type
7. Global Breast Biopsy Devices Market Analysis and Forecast, by Guidance Technique
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Guidance Technique, 2020-2034
7.3.1. Ultrasound-guided Biopsy
7.3.2. MRI-guided Biopsy
7.3.3. Mammography-guided Biopsy
7.3.4. Stereotactic-guided Biopsy
7.4. Market Attractiveness, by Guidance Technique
8. Global Breast Biopsy Devices Market Analysis and Forecast, by Application
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2020-2034
8.3.1. Screening
8.3.2. Diagnostic
8.3.3. Surveillance
8.4. Market Attractiveness, by Application
9. Global Breast Biopsy Devices Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Hospitals
9.3.2. Specialty Clinics
9.3.3. Diagnostic Imaging Centers
9.3.4. Ambulatory Surgical Centers
9.4. Market Attractiveness, by End-user
10. Global Breast Biopsy Devices Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Breast Biopsy Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2020-2034
11.2.1. Core Needle Biopsy Devices
11.2.2. Vacuum-assisted Biopsy Devices
11.2.3. Fine Needle Aspiration Biopsy Devices
11.2.4. Surgical Biopsy Devices
11.2.5. Others
11.3. Market Attractiveness, by Product Type
11.4. Market Value Forecast, by Guidance Technique, 2020-2034
11.4.1. Ultrasound-guided Biopsy
11.4.2. MRI-guided Biopsy
11.4.3. Mammography-guided Biopsy
11.4.4. Stereotactic-guided Biopsy
11.5. Market Attractiveness, by Guidance Technique
11.6. Market Value Forecast, by Application, 2020-2034
11.6.1. Screening
11.6.2. Diagnostic
11.6.3. Surveillance
11.7. Market Attractiveness, by Application
11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Hospitals
11.8.2. Specialty Clinics
11.8.3. Diagnostic Imaging Centers
11.8.4. Ambulatory Surgical Centers
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product Type
11.11.2. By Guidance Technique
11.11.3. By Application
11.11.4. By End-user
11.11.5. By Country
12. Europe Breast Biopsy Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2020-2034
12.2.1. Core Needle Biopsy Devices
12.2.2. Vacuum-assisted Biopsy Devices
12.2.3. Fine Needle Aspiration Biopsy Devices
12.2.4. Surgical Biopsy Devices
12.2.5. Others
12.3. Market Attractiveness, by Product Type
12.4. Market Value Forecast, by Guidance Technique, 2020-2034
12.4.1. Ultrasound-guided Biopsy
12.4.2. MRI-guided Biopsy
12.4.3. Mammography-guided Biopsy
12.4.4. Stereotactic-guided Biopsy
12.5. Market Attractiveness, by Guidance Technique
12.6. Market Value Forecast, by Application, 2020-2034
12.6.1. Screening
12.6.2. Diagnostic
12.6.3. Surveillance
12.7. Market Attractiveness, by Application
12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Hospitals
12.8.2. Specialty Clinics
12.8.3. Diagnostic Imaging Centers
12.8.4. Ambulatory Surgical Centers
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product Type
12.11.2. By Guidance Technique
12.11.3. By Application
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Breast Biopsy Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2020-2034
13.2.1. Core Needle Biopsy Devices
13.2.2. Vacuum-assisted Biopsy Devices
13.2.3. Fine Needle Aspiration Biopsy Devices
13.2.4. Surgical Biopsy Devices
13.2.5. Others
13.3. Market Attractiveness, by Product Type
13.4. Market Value Forecast, by Guidance Technique, 2020-2034
13.4.1. Ultrasound-guided Biopsy
13.4.2. MRI-guided Biopsy
13.4.3. Mammography-guided Biopsy
13.4.4. Stereotactic-guided Biopsy
13.5. Market Attractiveness, by Guidance Technique
13.6. Market Value Forecast, by Application, 2020-2034
13.6.1. Screening
13.6.2. Diagnostic
13.6.3. Surveillance
13.7. Market Attractiveness, by Application
13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Hospitals
13.8.2. Specialty Clinics
13.8.3. Diagnostic Imaging Centers
13.8.4. Ambulatory Surgical Centers
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product Type
13.11.2. By Guidance Technique
13.11.3. By Application
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Breast Biopsy Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2020-2034
14.2.1. Core Needle Biopsy Devices
14.2.2. Vacuum-assisted Biopsy Devices
14.2.3. Fine Needle Aspiration Biopsy Devices
14.2.4. Surgical Biopsy Devices
14.2.5. Others
14.3. Market Attractiveness, by Product Type
14.4. Market Value Forecast, by Guidance Technique, 2020-2034
14.4.1. Ultrasound-guided Biopsy
14.4.2. MRI-guided Biopsy
14.4.3. Mammography-guided Biopsy
14.4.4. Stereotactic-guided Biopsy
14.5. Market Attractiveness, by Guidance Technique
14.6. Market Value Forecast, by Application, 2020-2034
14.6.1. Screening
14.6.2. Diagnostic
14.6.3. Surveillance
14.7. Market Attractiveness, by Application
14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Hospitals
14.8.2. Specialty Clinics
14.8.3. Diagnostic Imaging Centers
14.8.4. Ambulatory Surgical Centers
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product Type
14.11.2. By Guidance Technique
14.11.3. By Application
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Breast Biopsy Devices Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2020-2034
15.2.1. Core Needle Biopsy Devices
15.2.2. Vacuum-assisted Biopsy Devices
15.2.3. Fine Needle Aspiration Biopsy Devices
15.2.4. Surgical Biopsy Devices
15.2.5. Others
15.3. Market Attractiveness, by Product Type
15.4. Market Value Forecast, by Guidance Technique, 2020-2034
15.4.1. Ultrasound-guided Biopsy
15.4.2. MRI-guided Biopsy
15.4.3. Mammography-guided Biopsy
15.4.4. Stereotactic-guided Biopsy
15.5. Market Attractiveness, by Guidance Technique
15.6. Market Value Forecast, by Application, 2020-2034
15.6.1. Screening
15.6.2. Diagnostic
15.6.3. Surveillance
15.7. Market Attractiveness, by Application
15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Hospitals
15.8.2. Specialty Clinics
15.8.3. Diagnostic Imaging Centers
15.8.4. Ambulatory Surgical Centers
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product Type
15.11.2. By Guidance Technique
15.11.3. By Application
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Hologic, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Becton, Dickinson and Company (BD)
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Medtronic
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Danaher Corporation
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Siemens Healthineers AG
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Mammotome (Devicor Medical Products, Inc.)
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Carestream Health
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. AURORA HEALTHCARE US CORP.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Stryker
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview